Anthropic's Claude AI has uncovered a new enzyme system, ART, in viral DNA, but its significance and potential use remain undefined.
Novel Enzyme Discovery by Anthropic's Claude
Anthropic has announced a significant discovery made by its AI model, Claude, which identified a previously unknown enzyme system within viral DNA. Named the ART system, short for array-associated reverse transcriptases, this finding raises questions about its biological role and practical applications.
The analysis was conducted over a span of 21 hours, during which Claude reviewed DNA databases, ultimately selecting 20 unusual candidates from an extensive pool of 200,000 enzymes. This ambitious search involved the collaboration of approximately 950 AI agents and processed around 210 million tokens.
Despite the novelty of the discovery, CEO Dario Amodei emphasized that the exact function and usefulness of the ART system are still unclear. He remarked on the analytical effort, suggesting it was an endeavor he would have been proud of as a PhD student, a sentiment met with skepticism by some critics who highlighted the lack of clarity surrounding the findings.
Reactions to the discovery have been mixed. CRISPR co-inventor Feng Zhang expressed intrigue at the findings, noting the potential for AI to contribute to biological discovery. Meanwhile, observers from the scientific community caution that while the discovery is promising, it will likely take years before any potential clinical applications could be realized. Furthermore, shares of companies in gene editing, such as CRISPR Therapeutics and Intellia Therapeutics, saw declines following the announcement, indicating market concern over the implications of this research.
Anthropic's announcement follows a pattern of presenting findings that require careful interpretation. In a prior instance, the company claimed that Claude Mythos had solved a complex problem in post-quantum cryptography, a claim that underwent extensive human validation before being accepted. As of now, Anthropic is continuing laboratory investigations to further explore the ART system.
